Published in J Infect Dis on December 15, 2014
Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol (2015) 1.00
Modeling mucosal cell-associated HIV type 1 transmission in vitro. J Infect Dis (2014) 0.84
Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness. Proc Natl Acad Sci U S A (2017) 0.84
HIV-1 cellular and tissue replication patterns in infected humanized mice. Sci Rep (2016) 0.80
Cell-associated HIV mucosal transmission: the neglected pathway. J Infect Dis (2014) 0.77
Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV. AIDS (2017) 0.76
Chlamydia trachomatis Infection of Endocervical Epithelial Cells Enhances Early HIV Transmission Events. PLoS One (2016) 0.76
HIV-1 is undetectable in preejaculatory secretions from HIV-1-infected men on suppressive HAART. AIDS (2016) 0.75
JAK-STAT Signaling Pathways and Inhibitors Affect Reversion of Envelope-Mutated HIV-1. J Virol (2017) 0.75
Monocytes but Not Lymphocytes Carrying HIV-1 on Their Surface Transmit Infection to Human Tissue Ex Vivo. J Virol (2016) 0.75
The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol (2004) 7.04
Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet (1997) 6.34
Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS (2000) 4.91
Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS (2007) 4.74
HTLV-III in the semen and blood of a healthy homosexual man. Science (1984) 4.53
Setting the stage: host invasion by HIV. Nat Rev Immunol (2008) 3.25
Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med (1998) 3.14
Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis (2000) 3.02
Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet (1997) 2.88
Potential HIV-1 target cells in the human penis. AIDS (2006) 2.84
The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis (2001) 2.79
Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod (2005) 2.48
Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis (2004) 2.45
Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA (1993) 2.41
Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis (1998) 2.27
Prospective study of leukocytes and leukocyte subpopulations in semen suggests they are not a cause of male infertility. Fertil Steril (1993) 2.12
Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings. Sex Transm Dis (2008) 2.06
Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis (1997) 2.02
A nested case-control study of sexual practices and risk factors for prevalent HIV-1 infection among young men in Kisumu, Kenya. Sex Transm Dis (2007) 2.01
Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr (1993) 1.91
Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS (2001) 1.88
T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis (1997) 1.85
Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis (1994) 1.70
Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. J Immunol (2011) 1.67
Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J Immunol (2012) 1.65
Association between cervical shedding of herpes simplex virus and HIV-1. AIDS (2002) 1.64
Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann Intern Med (1987) 1.59
Highly active antiretroviral therapy does not completely suppress HIV in semen of sexually active HIV-infected men who have sex with men. AIDS (2012) 1.56
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J Clin Invest (2011) 1.44
Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi. J Infect Dis (1998) 1.42
Targeting Trojan Horse leukocytes for HIV prevention. AIDS (2010) 1.40
Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil Steril (2007) 1.40
Clinical, microbiological, and biochemical factors in recurrent bacterial vaginosis. J Clin Microbiol (1992) 1.38
Pre-ejaculatory fluid as potential vector for sexual transmission of HIV-1. Lancet (1992) 1.32
Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases. BMJ (1996) 1.31
Continuous measurement by radio-telemetry of vaginal pH during human coitus. J Reprod Fertil (1973) 1.30
Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis (1999) 1.28
Association of genital shedding of herpes simplex virus type 2 and HIV-1 among sex workers in rural Zimbabwe. AIDS (2006) 1.27
Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model. BMC Infect Dis (2005) 1.26
Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum Reprod (2007) 1.26
Genital tract leukocytes and shedding of genital HIV type 1 RNA. Clin Infect Dis (2008) 1.25
Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen. J Infect Dis (1997) 1.21
High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix. J Infect Dis (2008) 1.18
Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency. J Infect Dis (2000) 1.18
Exposure to HIV-1 during delivery and mother-to-child transmission. AIDS (2000) 1.18
Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes. J Virol (2003) 1.14
Male genital tract inflammation associated with increased numbers of potential human immunodeficiency virus host cells in semen. Andrologia (1989) 1.13
Quantitation of mediators of inflammation and immunity in genital tract secretions and their relevance to HIV type 1 transmission. AIDS Res Hum Retroviruses (1998) 1.13
Vasectomy and human immunodeficiency virus type 1 in semen. J Urol (1998) 1.13
Immunohistologic characterization and quantitation of leukocyte subpopulations in human semen. Fertil Steril (1988) 1.12
Micronutrient supplementation increases genital tract shedding of HIV-1 in women: results of a randomized trial. J Acquir Immune Defic Syndr (2004) 1.12
Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis (2003) 1.11
Cervical and vaginal shedding of human immunodeficiency virus type 1-infected cells throughout the menstrual cycle. J Infect Dis (1998) 1.11
Elevated cervical white blood cell infiltrate is associated with genital HIV detection in a longitudinal cohort of antiretroviral therapy-adherent women. J Infect Dis (2010) 1.10
HIV-specific CD8+ lymphocytes in semen are not associated with reduced HIV shedding. J Immunol (2005) 1.09
Prevalence of human herpes virus types 1-7 in the semen of men attending an infertility clinic and correlation with semen parameters. Fertil Steril (2008) 1.08
Vaginal pH neutralization by semen as a cofactor of HIV transmission. Clin Microbiol Infect (1997) 1.07
Human immunodeficiency virus type 1--serodiscordant couples can bear healthy children after undergoing intrauterine insemination. Fertil Steril (1998) 1.06
Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions. BJOG (2001) 1.06
Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission. J Infect Dis (2000) 1.04
Comparison of methods to enumerate white blood cells in semen. Fertil Steril (1993) 1.03
Selenium deficiency is associated with shedding of HIV-1--infected cells in the female genital tract. J Acquir Immune Defic Syndr (2001) 1.01
HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells. Virology (2010) 0.99
The removal of morphologically abnormal sperm forms by phagocytes: a positive role for seminal leukocytes? Hum Reprod (1992) 0.97
Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy. J Acquir Immune Defic Syndr (2009) 0.97
T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected women. J Acquir Immune Defic Syndr (2007) 0.97
Seminal plasma induces programmed cell death in cultured peripheral blood mononuclear cells. AIDS Res Hum Retroviruses (2002) 0.97
The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions. Am J Obstet Gynecol (2005) 0.96
Delayed application of condoms is a risk factor for human immunodeficiency virus infection among homosexual and bisexual men. Am J Epidemiol (2003) 0.96
Chemotactic activity of urethral secretions in men with urethritis and the effect of treatment. J Infect Dis (1993) 0.96
Comparative prediction of perinatal human immunodeficiency virus type 1 transmission, using multiple virus load markers. J Infect Dis (2003) 0.95
Stability and transport of cervical cytobrushes for isolation of mononuclear cells from the female genital tract. J Immunol Methods (2011) 0.91
Identification of HIV-1 in semen following primary HIV-1 infection. AIDS (1992) 0.91
Role of spermine in the cytotoxic effects of seminal plasma. Am J Reprod Immunol Microbiol (1987) 0.90
HIV type 1 cervicovaginal reservoirs in the era of HAART. AIDS Res Hum Retroviruses (2005) 0.89
Antibodies to human immunodeficiency virus in the semen of heterosexual men. J Infect Dis (1989) 0.89
Selective transmigration of monocyte-associated HIV-1 across a human cervical monolayer and its modulation by seminal plasma. AIDS (2012) 0.88
Increased levels of HIV-1-infected cells in endocervical secretions after the luteinizing hormone surge. J Acquir Immune Defic Syndr (2008) 0.87
Detection of HIV-1-specific CTLs in the semen of HIV-infected individuals. J Immunol (1998) 0.87
Leukocytospermia and sperm preparation--a flow cytometric study. Reprod Biol Endocrinol (2009) 0.87
HIV-specific T-cell responses detected in the genital tract of chronically HIV-infected women are largely monofunctional. Immunology (2013) 0.84
(C2) Saliva, breast milk, and mucosal fluids in HIV transmission. Adv Dent Res (2006) 0.84
The effect of seminal plasma on macrophage function--a possible contributory factor in sexually transmitted disease. AIDS Res (1986) 0.83
Are seminal fluid microorganisms of significance or merely contaminants? Fertil Steril (2000) 0.83
Estimating the timing of mother-to-child transmission of the human immunodeficiency virus type 1 using a viral molecular evolution model. PLoS One (2014) 0.83
Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan women. J Acquir Immune Defic Syndr (2013) 0.83
Dendritic cells in semen of infertile men: association with sperm quality and inflammatory status of the epididymis. Fertil Steril (2013) 0.82
Semen quality of men with asymptomatic chlamydial infection. J Androl (2003) 0.82
Oxidative stress and interleukins in seminal plasma during leukocytospermia. Fertil Steril (1995) 0.81
Seminal immune response in infertile men with leukocytospermia: effect on antioxidant activity. Eur J Obstet Gynecol Reprod Biol (1999) 0.81
Role of semen in modulating the female genital tract microenvironment--implications for HIV transmission. Am J Reprod Immunol (2014) 0.81
Menstrual blood as a potential source of endometrial derived CD3+ T cells. PLoS One (2011) 0.81
Seminal shedding of human herpesviruses. Virol J (2013) 0.80
The use of serum-free medium delays, but does not prevent, the cytotoxic effects of seminal plasma in lymphocyte cultures: implications for studies on HIV infection. New Microbiol (1997) 0.80
Antibiotic therapy and leukocytospermia: a prospective, randomized, controlled study. Fertil Steril (1995) 0.80
Leucocyte subpopulations in the seminal plasma and their effects on fertilisation rates in an IVF cycle. Andrologia (2012) 0.79
Mother to infant transmission of HIV. Curr Opin Infect Dis (1999) 0.79
Isolation and characterization of T cells from semen. J Immunol Methods (2011) 0.79
Lymphocyte shedding from genital tract of human immunodeficiency virus-infected women: immunophenotypic and clinical correlates. Am J Obstet Gynecol (1997) 0.78